The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...
Biocon Ltd on Monday said its board has approved raising Rs 570 crore through issuance of commercial papers on private ...
Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...
PORTLAND, IA, UNITED STATES, January 28, 2025 /EINPresswire / -- According to the report, the global biosimilars <a target=_blank href= ...
SMC Global Securities said that Eicher Motors has been trading within a well-defined channel, and a breakout has occurred on ...
Bengaluru: Biocon Limited, a global biopharmaceuticals company, has announced its Environmental, Social and Governance (ESG) ...
India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...
Biocon's chairperson urges India's government to exempt cancer and chronic disease drugs from taxes to alleviate patient ...
Biocon Ltd has approved raising Rs 570 crore through issuance of commercial papers on private placement basis. The company also reported an improvement in its ESG scores.
Shaw, chairperson of Biocon Ltd, urges the Indian government to eliminate taxes on drugs for cancer and chronic diseases.
Biocon in its Environmental, Social and Governance (ESG) scores as assessed by S&P Global’s Corporate Sustainability Assessment (CSA) for 2024 has achieved an improvement to 69 in 2024, up 6 points ...
HYDERABAD, India (Reuters) - India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister ...